Project Grant K01DK143201
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded UCLA a $248,905 Project Grant effective September 1, 2025, through July 31, 2028, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds implementation research to develop and evaluate a social work-led screening and referral program designed to identify and address social determinants of health (SDOH), particularly food...
- Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $356,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026 through March 31, 2029. This award funds the Partnering with Adolescents to Choose and Implement Technology in the Management of Type 1 Diabetes (PAC-IT) initiative, which...
- Federal Project Grant Award Summary The University of California, San Francisco received a $383,051 Project Grant award dated July 15, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research project, scheduled for completion by March 31, 2030, develops and evaluates a risk communication aid designed to improve medication persistence with sodium glucose cotransporter...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Nemours Foundation $114,000 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on May 12, 2026, with a completion date of April 30, 2028. This Project Grant funds the development of provider-focused dissemination strategies for evidence-based psychosocial care in Type 1 Diabetes (T1D) treatment. The research team will conduct a...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Virginia a $1.44 million Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period May 1, 2026 through April 30, 2029. This ancillary research project will utilize data and peripheral blood mononuclear cell (PBMC) samples from the Environmental Determinants of Diabetes in the Young (TEDDY) longitudinal...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2,390,830 Project Grant to the University of California, San Francisco (UCSF) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 1, 2025, through August 31, 2029. This award funds the development of scalable and transplantable pancreatic islet organoids with engineered oxygenation to improve therapeutic...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $616,107 Project Grant to the University of California, Los Angeles (UCLA) on March 10, 2026, for an intersectional analysis of the Whole Person Care–Los Angeles (WPC-LA) social care intervention. Under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), UCLA will evaluate the long-term effectiveness of WPC-LA in addressing diabetes quality of...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of California, Irvine a $229,553 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) beginning September 1, 2025, and concluding August 31, 2027. This mixed-methods research study will investigate non-clinical donor factors affecting post-donation follow-up care for living kidney donors and evaluate telemedicine...
- Federal Grant Award Summary Scripps Health received a $165,541 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with completion targeted for July 31, 2030. This K01 career development award supports Dr. San Diego's research to integrate continuous glucose monitoring (CGM) technology into diabetes self-management education...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Alabama at Birmingham $152,524.00 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on May 15, 2026, for a five-year research initiative extending through March 31, 2031. This K01 career development award supports Dr. Seung-Yup "Joshua" Lee in developing an independent research program focused on improving diabetes...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $151,448 to the University of California, Davis on May 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and pilot test a patient-centered virtual intervention addressing the critical healthcare transition period for adolescents and young adults (AYAs) with Type 1 Diabetes (T1D). The research applies implementation science methodology across three primary objectives: developing implementation strategies using capacity, organization, motivation-behavior (COM-B) theoretical constructs; conducting a randomized pilot trial of the virtual intervention incorporating peer mentorship, healthcare navigation education, and transition planning; and surveying pediatric endocrinology practices nationally to identify existing transition resources, implementation barriers, and scaling opportunities. The project, with a completion date of January 31, 2031, addresses a significant clinical gap by creating a scalable, resource-efficient alternative to traditional transition interventions, which are often clinician or system-dependent and have limited accessibility. The intervention components—developed through human-centered design—are designed to reduce healthcare lapses during the transition from pediatric to adult care that typically result in worsening health outcomes and increased emergency department utilization. This work will establish foundational evidence and implementation strategies supporting a future multi-center hybrid effectiveness-implementation trial to improve transition outcomes for AYAs with T1D.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $151.4k | 5/7/26 |